Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Medtronic
McKesson
Baxter
Merck

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Semapimod

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Semapimod?

Semapimod is an investigational drug.

There have been 5 clinical trials for Semapimod. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2002.

The most common disease conditions in clinical trials are Crohn Disease and [disabled in preview]. The leading clinical trial sponsors are Ferring Pharmaceuticals and [disabled in preview].

Recent Clinical Trials for Semapimod
TitleSponsorPhase
Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)Ferring PharmaceuticalsPhase 1
Extension Study of Semapimod 60 mg IV x 3 DaysFerring PharmaceuticalsPhase 2
Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's DiseaseFerring PharmaceuticalsPhase 2

See all Semapimod clinical trials

Clinical Trial Summary for Semapimod

Top disease conditions for Semapimod
Top clinical trial sponsors for Semapimod

See all Semapimod clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Mallinckrodt
AstraZeneca
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.